Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARγ

Journal of Neurochemistry

Volumn 81, Issue 5, 2002, Pages 1052-1060

  Zander, Thomas ^a   Kraus, Jürgen A ^a   Grommes, Christian ^d   Schlegel, Uwe ^a   Feinstein, Douglas ^b   Klockgether, Thomas ^a   Landreth, Gary ^c   Koenigsknecht, Jessica ^b   Heneka, Michael T ^a,b  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NONE

Author keywords

Apoptosis; Bax antisense; Human glioma; N cadherin; PPAR ; Redifferentiation

Indexed keywords

2,2 BIS(4 GLYCIDYLOXYPHENYL)PROPANE; 4,4' ISOPROPYLIDENEDIPHENOL; CIGLITAZONE; DNA FRAGMENT; LY 171833; NERVE CELL ADHESION MOLECULE; OLIGONUCLEOTIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIRINIXIC ACID; PROSTAGLANDIN J2; PROTEIN BAD; PROTEIN BAX; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; CHROMATIN CONDENSATION; COMET ASSAY; CONTROLLED STUDY; GLIOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-ASSOCIATED DEATH PROTEIN; CADHERINS; CARRIER PROTEINS; CELL DIVISION; CELL SURVIVAL; DNA FRAGMENTATION; DRUG EVALUATION, PRECLINICAL; GLIOMA; HUMANS; NUCLEAR PROTEINS; OLIGONUCLEOTIDES, ANTISENSE; PROSTAGLANDIN D2; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PYRIMIDINES; RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; THIAZOLES; THIAZOLIDINEDIONES; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

ANIMALIA; MURINAE;

EID: 0036316288     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.00899.x     Document Type: Article

References (35)

1. The International Comet Assay Workshop
2. Expression of cadherin and CSF dissemination in malignant astrocytic tumors
3. Rejoining of DNA single- and double-strand breaks in human white blood cells exposed to ionizing radiation
4. {[omega-(heterocyclylamino)alkoxy]benzyl}-2,4-thiazolidinediones as potent antihyperglycemic agents
5. Expression of peroxisome proliferator-activated receptors (PPARS) in human astrocytic cells: PPAR gamma agonists as inducers of apoptosis
6. Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells
7. Distribution of mRNAs encoding the peroxisome proliferator-activated receptor alpha, beta, and gamma and the retinoid X receptor alpha, beta, and gamma in rat central nervous system
8. Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: A general mechanism to accumulate effector cells in inflammation
9. Peroxisome proliferator-activated receptor gamma induces pancreatic cancer cell apoptosis
10. Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice
11. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults
12. Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro
13. 15-Deoxy-delta-12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma
14. Adjuvant therapy with dibromodulcitol and BCNU increases survival of adults with malignant gliomas
15. Occurrence of 9-deoxy-delta 9,delta 12-13, 14-dihydroprostaglandin D2 in human urine
16. Radiosensitivity, apoptosis and repair of DNA double-strand breaks in radiation-sensitive Chinese hamster ovary cell mutants treated at different dose rates
17. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
18. The new WHO classification of brain tumours
19. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors
20. Progress in cardiovascular biology: PPAR for the course
21. Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice
22. Peroxisome proliferator-activated receptors: A nuclear receptor signaling pathway in lipid physiology
23. Chemotherapy for brain tumors of astrocytic and oligodendroglial lineage: The past decade and where we are heading
24. 2 induces apoptosis of human hepatic myofibroblasts a pathway involving oxidative stress independently of peroxisome-proliferator-activated receptors
25. Terminal differentiation of human breast cancer through PPAR gamma
26. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells
27. A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme
28. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase
29. Differentiation and reversal of malignant changes in colon cancer through PPARgamma
30. Activation of PPARgamma inhibits cell growth and induces apoptosis in human gastric cancer cells
31. Modulation of cell death in yeast by the Bcl-2 family of proteins
32. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferatoractivated receptor gamma and the retinoid X receptor
33. The PPARs: From orphan receptors to drug discovery
34. A synthetic antagonist for the peroxisome proliferator-activated receptor gamma inhibits adipocyte differentiation
35. Bad, a heterodimeric partner for Bcl-XL and bcl-2, displaces Bax and promotes cell death